M. Leibenhaut

发表

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.

W. Curran, M. Mehta, R. Timmerman, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The changing role of staging laparotomy in the management of Hodgkin's disease.

M. Leibenhaut, 1993, Cancer treatment and research.

Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.

Christopher U. Jones, H. Sandler, J. Efstathiou, 2016, European urology.

Cardiovascular mortality following short-term androgen deprivation in clinically localized prostate cancer: An analysis of RTOG 94-08.

Christopher U. Jones, H. Sandler, J. Efstathiou, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraluminal low-dose rate brachytherapy for malignant endobronchial obstruction.

R. Weinstein, J. Beamis, D. Webb-Johnson, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

1. The changing role of staging laparotomy in the management of Hodgkin's disease

M. Leibenhaut, 1993 .

Survival a nd N eurologic O utcomes i n a R andomized T rial o f Motexafin G adolinium a nd W hole-Brain R adiation T herapy i n Brain M etastases

W. Curran, M. Mehta, R. Timmerman, 2003 .

Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.

S. Rosenthal, C. Brooks, H. Wolkov, 1996, Radiology.

Phase II trial of motexafin gadolinium (MGd, xcytrin®) and cranial radiation in newly diagnosed glioblastoma multiforme (GBM)

M. Mehta, R. Timmerman, L. Gaspar, 2002 .

Motexafin gadolinium prolongs time to neurologic progression in lung cancer patients with brain metastases: results of a randomized phase III trial

W. Curran, M. Mehta, Jennifer A. Smith, 2002 .

Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.

D. Fleming, A. Hightower, C. Broome, 1985, JAMA.

Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease.

B. Efron, S. Rosenberg, J. Halpern, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy and short-term androgen deprivation for localized prostate cancer.

Christopher U. Jones, H. Sandler, M. Amin, 2011, The New England journal of medicine.

Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.

W. Curran, M. Mehta, Jennifer A. Smith, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Subdiaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients.

S. Rosenberg, A. Varghese, R. Hoppe, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

Christopher U. Jones, J. Torres-Roca, H. Sandler, 2015, International journal of radiation oncology, biology, physics.

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408

Christopher U. Jones, H. Sandler, A. Raben, 2017, Advances in radiation oncology.

Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.

Christopher U. Jones, R. Mak, H. Sandler, 2016, Urologic oncology.

Economic Analysis of Radiation Therapy Oncology Group 97-14: Multiple Versus Single Fraction Radiation Treatment of Patients With Bone Metastases

W. Curran, N. Janjan, M. Roach, 2009, American journal of clinical oncology.

Management of invasive squamous cell carcinoma of the bulbomembranous male urethra with co-ordinated chemo-radiotherapy and genital preservation.

M. Silverman, R. Oberfield, L. Zinman, 1996, British journal of urology.

Adding short-term androgen deprivation therapy to RT in men with localized prostate cancer: long-term update of the NRG/RTOG 9408 randomized clinical trial.

Christopher U. Jones, A. Zietman, H. Sandler, 2021, International journal of radiation oncology, biology, physics.

Short-term Endocrine Therapy Prior to and during Radiation Therapy Improves Overall Survival in Patients with T1b-T2b Adenocarcinoma of the Prostate and PSA ≤ 20: Initial Results of RTOG 94-08

Christopher U. Jones, H. Sandler, M. Amin, 2010 .

Inferior Clinical Outcomes for Patients With Positive Post-Radiation Therapy Prostate Biopsy: Results From Prospective Randomized Trial RTOG 94-08

Christopher U. Jones, J. Bahary, E. Gore, 2013 .

Radiation Therapy Oncology Group (RTOG) 9408: A Secondary Analysis of the Risk of Death From Second Cancers Comparing Whole Pelvic (WP) Radiation Therapy (RT) to Prostate Only (PO) RT and Neoadjuvant Hormonal Therapy (NHT) + RT to RT Alone

Christopher U. Jones, H. Sandler, M. Roach, 2013 .

Cardiovascular mortality following short-term androgen deprivation in clinically localized prostate cancer: An analysis of RTOG 94-08.

Christopher U. Jones, H. Sandler, J. Efstathiou, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Economic Analysis of Radiation Therapy Oncology Group 97-14: Multiple Versus Single Fraction Radiation Treatment of Patients With Bone Metastases

W. Curran, N. Janjan, M. Roach, 2009, American journal of clinical oncology.

Is pelvic RT necessary in the treatment of stage I testicular seminoma

Christopher U. Jones, S. Rosenthal, A. Russell, 1998 .